Elsevier

The Lancet

Volume 376, Issue 9749, 16–22 October 2010, Pages 1275-1276
The Lancet

Comment
Intensive care medicine: a specialty coming to LIFE

https://doi.org/10.1016/S0140-6736(10)61502-4Get rights and content

References (12)

  • HC Lassen

    A preliminary report on the 1952 epidemic of poliomyelitis in Copenhagen with special reference to the treatment of acute respiratory insufficiency

    Lancet

    (1953)
  • J-L Vincent et al.

    Critical care: advances and future perspectives

    Lancet

    (2010)
  • NKJ Adhikari et al.

    Critical care and the global burden of critical illness in adults

    Lancet

    (2010)
  • JR Curtis et al.

    Ethics and end-of-life care for adults in the intensive care unit

    Lancet

    (2010)
  • NA Halpern et al.

    Critical care medicine in the United States 2000–2005: an analysis of bed numbers, occupancy rates, payer mix, and costs

    Crit Care Med

    (2010)
  • B Ibsen

    The anaesthetist's viewpoint on the treatment of respiratory complications in poliomyelitis during the epidemic in Copenhagen, 1952

    Proc R Soc Med

    (1954)
There are more references available in the full text version of this article.

Cited by (12)

  • A critical and evidence based glance at some of the major publications in Critical Care in 2011

    2012, Trends in Anaesthesia and Critical Care
    Citation Excerpt :

    However, despite numerous disappointments of large multi-centre trials in critical care, one must consider the major contribution of these large RCTs and subsequent systematic reviews since they have provided us with valuable information on the adverse effects of for instance overtreatment in ICU (i.e., high tidal volume ventilation, high calorie intake, high degree of sedation and liberal transfusion strategies).56–59 To this date, interventions such as early appropriate antibiotic treatment of bloodstream infection, surgical infectious source removal in sepsis, enteral nutrition, weaning from mechanical ventilation, early mobilisation and early volume resuscitation in sepsis have been significantly more superior to many of the immuno-modulatory interventions such as APC, Antithrombin III, Centoxin, tight glycaemic control and steroids.11,53,55,59–63 In order to improve outcomes of ICU patients, not only is there a need for better understanding of the underlying patho-physiological processes and mechanisms of actions, but there is also a continuous need for high quality, large clinical trials in accordance to CONSORT statement, high quality systematic reviews adhering to PRISMA guidelines and updated and low-bias international guidelines.

  • The future of intensive medicine

    2011, Medicina Intensiva
  • Intensive medicine in Spain

    2011, Medicina Intensiva
  • Intensive medicine in Europe: A need

    2011, Medicina Intensiva
View all citing articles on Scopus
View full text